Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abatement, adjudicated, adjudication, ai, aimed, al, ALC, AMC, ANC, Andersen, antagonism, antagonize, anti, Balixafortide, beleive, Bristol, brokerage, BTKi, capsule, Cede, choice, CN, CNS, Cohort, correlated, cutoff, cyclic, deeper, Depository, dismissed, DTC, dysregulation, enduring, Epidemiology, evaluted, exploratory, extrapolation, fever, filer, filgrastim, frontline, genomic, genotypically, granulocyte, ID, immunostimulatory, ing, instructed, intermittently, IPM, killer, Lincoln, LPC, Med, microliter, military, missense, monocyte, monocytopenia, motixafortide, Nemetz, Nivestym, older, oropharyngeal, overactivation, periphery, phenotype, phenotypically, PID, Qessential, querying, rata, refine, refractory, rollforward, Russian, shielding, Singapore, skin, spectrum, transmit, Treg, Trust, Ukraine, WBC, weaker, Zarxio
Removed:
bank, Cadillac, Circuit, circumvent, composition, comprised, concentration, contractually, conversion, dated, device, DRC, excise, FFG, indefinite, intermediate, judge, Korea, leasehold, lessor, line, mandated, marker, match, Merck, optimized, Pfizer, pharmacokinetic, poor, progression, regimen, RSV, shared, Silicon, substitute, survival, suspected, SVB, taxation, top, Trump, Valley, vitro, vivo
Filing tables
Filing exhibits
Related press release
Associated XFOR transcripts
XFOR similar filings
Filing view
External links